Hydrazin – Addendum: Aussetzung der EKA
The MAK Collection for Occupational Health and Safety · 2024 · 9 (3)
DOI: 10.34865/bb30201d9_3ad ↗Kurz gefasst
Fachartikel in der Zeitschrift The MAK Collection for Occupational Health and Safety, 2024. Verfasst von Greiner und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The German Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission) re-evaluated the data for the derivation of exposure equivalents for carcinogenic substances (EKA) for hydrazine [302-01-2]. Relevant studies were identified from a literature search. The EKA for hydrazine in air and hydrazine in urine as well as for hydrazine in plasma, established in 1991, were essentially based on unpublished data. Moreover, relevant studies appeared since the last evaluation, which point to major limitations for the use of EKA for hydrazine in urine and plasma. Therefore, the EKA are withdrawn.
Schlagwörter
Zitieren
APA
Greiner, Annette, Leng, Gabriele, Drexler, Hans, Hartwig, Andrea, & Commission, M. (2024). Hydrazin – Addendum: Aussetzung der EKA. The MAK Collection for Occupational Health and Safety, 9(3). https://doi.org/10.34865/bb30201d9_3ad
Vancouver
Greiner, Annette, Leng, Gabriele, Drexler, Hans, et al. Hydrazin – Addendum: Aussetzung der EKA. The MAK Collection for Occupational Health and Safety. 2024;9(3). doi:10.34865/bb30201d9_3ad
BibTeX
@article{Greiner2024,
author = {Greiner and Annette and Leng and Gabriele and Drexler and Hans and Hartwig and Andrea and Commission, MAK},
title = {Hydrazin – Addendum: Aussetzung der EKA},
journal = {The MAK Collection for Occupational Health and Safety},
year = {2024},
volume = {9},
number = {3},
doi = {10.34865/bb30201d9_3ad}
}
EUVIMED